7969 Results
1

Combination therapy is not beneficial for certain patients with ovarian cancer

March 20, 2025

OncLive and MedPage Today highlighted research presented by the University of Cincinnati Cancer Center's Thomas Herzog that found a combination therapy of afuresertib and paclitaxel did not lead to better survival outcomes when compared to only treating with paclitaxel in patients with platinum-resistant ovarian cancer.

2

Add-on metformin promising in ER-positive endometrial cancer

March 24, 2025

The University of Cincinnati Cancer Center's Amanda Jackson was featured in a MedPage Today article commenting on new research that found adding metformin as a combination therapy was tied to deep responses and prolonged progression-free survival in some patients with recurrent estrogen receptor-positive endometrial cancer.

6

UC COVID-19 studies awarded $425K

April 15, 2020

Understanding that time was of the essence in combating this highly infectious disease, UC and its College of Medicine’s Office of Research conducted a rapid review and distribution of $425,000 in novel pilot grants to researchers, focusing on eradicating the disease.

10

Combating ‘chemobrain’ with music

August 17, 2020

UC researchers from the College of Medicine and DAAP are working together to see how a music app may help patients who experience "chemobrain."